SCHEMBL26511520

SCHEMBL26511520

COCC1(CN(C)C(=O)CC(C)(C)CC(C)=O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26501351 0.73 — —
SCHEMBL19086787 0.73 LTC4S (0.32) —
SCHEMBL21470902 0.68 — —
SCHEMBL23086621 0.67 USP2 (0.32) —
SCHEMBL20095288 0.65 KDM5A (0.40) —
SCHEMBL23957363 0.64 OPRM1 (0.33) —
SCHEMBL2612030 0.63 ALDH1A1 (0.41) —
SCHEMBL18812066 0.60 GAA (0.35) —
SCHEMBL26517662 0.60 — —
SCHEMBL11026137 0.59 MGAM (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024055112-A1 BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2024-03-21 — — WO disclosed
WO-2023205892-A1 CDK INHIBITORS AND PHARMACEUTICAL USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2023-11-02 — — WO disclosed
WO-2023193085-A1 BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF RISEN (SUZHOU) PHARMA TECH Co.,Ltd. (CN) 2023-10-12 — — WO disclosed
Send feedback